# EDGAR Filing Document

**Accession Number:** 0001929783
**File Stem:** 0001213900-26-032326
**Filing Date:** 2026-3
**Character Count:** 12299
**Document Hash:** c3faf67172f739397bf5f24ac6e86e24
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-032326.hdr.sgml**: 20260320

**ACCESSION NUMBER**: 0001213900-26-032326

**CONFORMED SUBMISSION TYPE**: 20-F/A

**PUBLIC DOCUMENT COUNT**: 16

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20260320

**DATE AS OF CHANGE**: 20260320

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** WORK Medical Technology Group LTD
- **CENTRAL INDEX KEY:** 0001929783
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** F4
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 20-F/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42256
- **FILM NUMBER:** 26778134

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** BUILDING 23, NO. 2 TONGHUINAN RD.
- **STREET 2:** XIAOSHAN DISTRICT
- **CITY:** HANGZHOU
- **PROVINCE COUNTRY:** F4
- **ZIP:** 311200
- **BUSINESS PHONE:** 86-0571-82613568

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** BUILDING 23, NO. 2 TONGHUINAN RD.
- **STREET 2:** XIAOSHAN DISTRICT
- **CITY:** HANGZHOU
- **PROVINCE COUNTRY:** F4
- **ZIP:** 311200

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** WORK Medical Technology LTD
- **DATE OF NAME CHANGE:** 20220518

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 20-F/A**

**(Amendment No. 1)**

☐ **REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934**

**OR**

☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the fiscal year ended September 30, 2025**

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**OR**

☐ **SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

Date of event requiring this shell company report

**For the transition period from &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;** 

Commission file number: 001-42256

**WORK Medical Technology Group LTD**

(Exact name of Registrant as specified in its charter)

**N/A**

(Translation of Registrant's name into English)

**Cayman Islands**

(Jurisdiction of incorporation or organization)

**Floor 23, No. 2 Tonghuinan Road**

**Xiaoshan District, Hangzhou City, Zhejiang Province**

**The People's Republic of China**

**+86-571-82613568**

(Address of principal executive offices)

**Shuang Wu, Chief Executive Officer**

**Telephone: +86-571-82613568**

**Email: wushuang@workmedtech.com**

**Floor 23, No.2 Tonghuinan Road**

**Xiaoshan District, Hangzhou City, Zhejiang Province**

**The People's Republic of China**

**+86-571-82613568**

(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

**Securities registered or to be registered pursuant to Section 12(b) of the Act.**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| **Class A Ordinary Shares** | **WOK** | **The Nasdaq Stock Market** |

---

Securities registered or to be registered pursuant to Section 12(g) of the Act.

**None**

(Title of Class)

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act.

**None**

(Title of Class)

Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report.

An aggregate of 95,998,776 Class A Ordinary Shares, par value $0.05 per share, and 7,592,500 Class B Ordinary Shares, par value $0.05 per share, as of September 30, 2025.

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes ☐ No ☒

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Yes ☐ No ☒

Note – Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of "large accelerated filer," "accelerated filer," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Emerging growth company ☒

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive- based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

U.S. GAAP ☒ International Financial Reporting Standards as issued by the International Accounting Standards Board ☐ Other ☐

\* If "Other" has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow. Item 17 ☐ Item 18 ☐

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes ☐ No ☐

<u>Auditor Name</u> <u>Auditor Location</u> <u>Auditor Firm ID</u> <br> WWC, P.C. San Mateo, California PCAOB ID No. 1171 <br> HTL International, LLC Houston, Texas PCAOB ID No. 7000

**EXPLANATORY NOTE**

WORK Medical Technology Group LTD ("we," "us," "the Company," "our" or "WOK") is filing this Amendment No. 1 to Form 20-F (the "Form 20-F/A") to its annual report on Form 20-F for the year ended September 30, 2025 (the "Annual Report"), which was originally filed with the U.S. Securities and Exchange Commission (the "SEC") on January 30, 2026. The sole purpose of this Form 20-F/A is an exhibit-only filing to amend the Form 20-F to file the Exhibit 15.2 and Exhibit 15.3. No other changes have been made to the Annual Report as amended by Amendment No. 1.

This Form 20-F/A does not reflect events occurring after the filing of the Annual Report and does not modify or update the disclosure therein in any way except as described above. No other changes have been made to the Annual Report. The filing of this Form 20-F/A should not be understood to mean that any statements contained in the Annual Report and this Form 20-F/A, are true or complete as of any date subsequent to the original filing date of the Annual Report. Accordingly, this Form 20-F/A should be read in conjunction with the Annual Report.

**Item 19. EXHIBITS**

**EXHIBIT INDEX** 

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| [15.2\*](ea028272201ex15-2.htm) | [Consent of WWC, P.C., regarding the incorporation by reference the report dated February 14, 2025 in this Annual Report on Form 20-F](ea028272201ex15-2.htm) |
| [15.3\*](ea028272201ex15-3.htm) | [Consent of HTL International, LLC, regarding the incorporation by reference the report dated January 30, 2026 in this Annual Report on Form 20-F](ea028272201ex15-3.htm) |
| 104\* | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

\* Filed with this Form 20-F/A

**SIGNATURES**

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F/A and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

---

| | |
|:---|:---|
| WORK Medical Technology Group LTD | WORK Medical Technology Group LTD |
| By: | /s/ Shuang Wu |
|  | Shuang Wu |
|  | Chief Executive Officer, Director, and |
|  | Chairman of the Board of Directors |

---

Date: March 20, 2026

## Exhibit 15.2

**Exhibit 15.2**

**<u>Consent of Independent Registered Public Accounting Firm</u>**

We hereby consent to the incorporation by reference of our report dated February 14, 2025 in the Company's Annual Report on Form 20-F, as amended, relating to the audit of the consolidated balance sheets of Work Medical Technology Group Ltd and its subsidiaries (collectively the "Company") as of September 30, 2024 and 2023 and the related consolidated statements of income and comprehensive loss, changes in equity, and cash flows in each of the years in the three year period ended September 30, 2024, and the related notes (collectively referred to as the financial statements) included in its Registration Statement on Form F-3 (File No. 333-289943) filed with the U.S. Securities and Exchange Commission on August 29, 2025.

We also consent to the reference to our firm under the heading "Experts" in such Registration Statement.

We were dismissed as auditors on July 30, 2025, and, accordingly, we have not performed any audit or review procedures with respect to any financial statements included in such Form for the periods subsequent to September 30, 2024.

---

| | |
|:---|:---|
|  | /s/ WWC, P.C. |
| San Mateo, California | WWC, P.C. |
| March 20, 2026 | Certified Public Accountants |
|  | PCAOB ID: 1171 |

---

![](ea028272201_ex15-2img2.jpg)

## Exhibit 15.3

**Exhibit 15.3**

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form F-3 (No. 333-289943) of WORK Medical Technology Group LTD and its subsidiaries (the "Company") of our report dated January 30, 2026, relating to the consolidated balance sheet of the Company as of September 30, 2025 and the related consolidated statements of loss and comprehensive loss, changes in shareholders' equity, and cash flows for the year ended September 30, 2025, and the related notes, included in the Company's Annual Report on Form 20-F, as amended, for the year ended September 30, 2025.

We also consent to the reference to our firm under the heading "Experts" in such Registration Statement.

/s/ HTL International, LLC

Houston, Texas

March 20, 2026